.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
Julphar
Citi
Moodys
Cipla
Farmers Insurance
Mallinckrodt
Fuji
Boehringer Ingelheim

Generated: September 25, 2017

DrugPatentWatch Database Preview

EMADINE Drug Profile

« Back to Dashboard

What is the patent landscape for Emadine, and what generic Emadine alternatives are available?

Emadine is a drug marketed by Novartis Pharms Corp and is included in one NDA.

The generic ingredient in EMADINE is emedastine difumarate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the emedastine difumarate profile page.

Summary for Tradename: EMADINE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list13
Patent Applications: see list1,025
Drug Prices:see details
DailyMed Link:EMADINE at DailyMed

Pharmacology for Tradename: EMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 1997RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 1997► Subscribe► Subscribe
Novartis Pharms Corp
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Novartis
Farmers Insurance
Harvard Business School
Cantor Fitzgerald
Queensland Health
Boehringer Ingelheim
Fish and Richardson
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot